Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$460,653,157
-$64,521,417 QoQ
Shares Held
2,429,349
-8.8% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#57
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names. AZN ranks #1 (34.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
|
3,855 | $970,072 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,653,157 | 2,429,349 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $525,174,574 | 2,662,887 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||